Dose the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study : A Multicenter, randomized, double-blind, placebo-control trial

• The MERCATOR study Group

Journal

• Circulation

  Circulation 86 100-110, 1992

Details

• CRID: 1572261549593258368
• NII Article ID: 10008615066
• Data Source:
  • CiNii Articles